Auour Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Hold
300
0.1% 72
2026
Q1
$276K Hold
300
0.09% 80
2025
Q4
$322K Hold
300
0.1% 71
2025
Q3
$229K Hold
300
0.07% 80
2025
Q2
$234K Hold
300
0.08% 73
2025
Q1
$270K Hold
300
0.1% 65
2024
Q4
$243K Hold
300
0.09% 78
2024
Q3
$271K Hold
300
0.1% 68
2024
Q2
$272K Hold
300
0.1% 66
2024
Q1
$233K Buy
+300
New +$214K 0.09% 72

Other funds holding LLY

Auour Investments's LLY Position: Q2 2026 in Review

Auour Investments held its Eli Lilly (LLY) position steady in Q2 2026 at 300 shares worth $360K. The position accounts for 0.1% of the portfolio, ranked #72.

Auour Investments first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Auour Investments held 300 shares of Eli Lilly worth $360K as of Q2 2026.
  • Auour Investments left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.1% of Auour Investments's portfolio in Q2 2026, its #72 holding.
  • Auour Investments first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Auour Investments's 13F filing for Q2 2026, filed 21 Jul 2026.